Evidence map›Paper›PMID 19517019›Full record

ArticlePloS one2009

p63 promotes cell survival through fatty acid synthase.

Venkata Sabbisetti, Arianna Di Napoli, Apryle Seeley, Angela M Amato, Esther O'Regan, Musie Ghebremichael, Massimo Loda, Sabina Signoretti

RetractedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Acetyl-CoA-mediated autoacetylation of fatty acid synthase as a metabolic switch of de novo lipogenesis inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Venkata SabbisettiDepartment of Pathology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Arianna Di Napoli
Apryle Seeley
Angela M Amato
Esther O'Regan
Musie Ghebremichael
Massimo Loda
Sabina Signoretti
Brigham and Women's Hospital · USDana-Farber Cancer Institute · USDana-Farber Brigham Cancer Center · USSt. James's Hospital · IE

Funding

Molecular Link Between Metabolic Syndrome and Prostate CancerR01CA131945 · NCI · DANA-FARBER CANCER INST · PI LODA, MASSIMO · 2008 to 2018
$4.0M
Defining Cell Lineages in the Bladder UrotheliumR21DK072152 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SIGNORETTI, SABINA · 2005 to 2006
$467k
NCI NIH HHS R01 CA131945NIDDK NIH HHS R21 DK072152NIDDK NIH HHS R21 DK72152
6 · The paper itself

Abstract

There is increasing evidence that p63, and specifically DeltaNp63, plays a central role in both development and tumorigenesis by promoting epithelial cell survival. However, few studies have addressed the molecular mechanisms through which such important function is exerted. Fatty acid synthase (FASN), a key enzyme that synthesizes long-chain fatty acids and is involved in both embryogenesis and cancer, has been recently proposed as a direct target of p53 family members, including p63 and p73. Here we show that knockdown of either total or DeltaN-specific p63 isoforms in squamous cell carcinoma (SCC9) or immortalized prostate epithelial (iPrEC) cells caused a decrease in cell viability by inducing apoptosis without affecting the cell cycle. p63 silencing significantly reduced both the expression and the activity of FASN. Importantly, stable overexpression of either FASN or myristoylated AKT (myr-AKT) was able to partially rescue cells from cell death induced by p63 silencing. FASN induced AKT phosphorylation and a significant reduction in cell viability was observed when FASN-overexpressing SCC9 cells were treated with an AKT inhibitor after p63 knockdown, indicating that AKT plays a major role in FASN-mediated survival. Activated AKT did not cause any alteration in the FASN protein levels but induced its activity, suggesting that the rescue from apoptosis documented in the p63-silenced cells expressing myr-AKT cells may be partially mediated by FASN. Finally, we demonstrated that p63 and FASN expression are positively associated in clinical squamous cell carcinoma samples as well as in the developing prostate. Taken together, our findings demonstrate that FASN is a functionally relevant target of p63 and is required for mediating its pro-survival effects.

Indexed as

ApoptosisCarcinoma, Squamous CellCell CycleCell Line, TumorCell SurvivalDNA-Binding ProteinsEpithelial CellsFatty Acid SynthasesGene SilencingHumansMembrane ProteinsModels, BiologicalMyristic AcidsNuclear ProteinsPhosphorylationProtein IsoformsCKAP4 protein, humanDNA-Binding ProteinsFatty Acid SynthasesMembrane ProteinsMyristic AcidsNuclear ProteinsProtein IsoformsTP73 protein, humanTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID19517019
PMCPMC2691576
OpenAlexW2162678621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.